Yan Ming 4

What Happened
Yan Ming, Chief Technology Officer and a director at Cytek Biosciences (CTKB), reported a gift (transaction code G) of 135,892 shares on 2026-06-12. The filing shows a $0.00 per-share price and $0 total proceeds, indicating a non‑sale transfer (a disposal of shares by gift). The Form 4 was filed on 2026-06-16 (accession 0001874041-26-000007).

Key Details

• Transaction date: 2026-06-12; Form 4 filed: 2026-06-16.
• Shares transferred: 135,892; reported price: $0.00; total cash proceeds: $0.
• Shares owned after the transaction: not specified in the information provided in this summary — see the filed Form 4 for the insider’s post-transaction holdings.
• Footnotes/plan info: none provided in the data supplied here; recipient of the gift not specified.
• Timeliness: filing date is four days after the transaction date; Form 4s are typically due within two business days, so check the official filing for any late-filing disclosure or explanations.

Context
Gifts are transfers, not market purchases or sales; they do not generate cash proceeds for the donor and generally do not directly signal the insider’s view of the company’s outlook. Common reasons include family transfers, charitable donations, or estate/tax planning. For investors, purchases by insiders tend to be more informative about confidence than gifts or routine disposals.